{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:51:29Z","timestamp":1791510689466,"version":"4.3.4"},"reference-count":103,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.rdc.2026.07.003","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:50:00Z","timestamp":1787777400000},"page":"687-706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ocular Manifestations in Rheumatic Diseases"],"prefix":"10.1016","volume":"52","author":[{"given":"Lara","family":"Srour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina","family":"Kazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rula A.","family":"Hajj-Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.rdc.2026.07.003_bib1","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ajo.2004.08.043","article-title":"Uveitis: fundamentals and clinical practice, third edition","volume":"138","author":"Rosenbaum","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.rdc.2026.07.003_bib2","series-title":"StatPearls","article-title":"Uveitis","author":"Duplechain","year":"2025"},{"key":"10.1016\/j.rdc.2026.07.003_bib3","series-title":"StatPearls","article-title":"Episcleritis","author":"Schonberg","year":"2025"},{"key":"10.1016\/j.rdc.2026.07.003_bib4","series-title":"StatPearls","article-title":"Scleritis","author":"Lagina","year":"2025"},{"issue":"9","key":"10.1016\/j.rdc.2026.07.003_bib5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.revmed.2014.02.004","article-title":"[Scleritis and episcleritis: diagnosis and treatment]","volume":"35","author":"H\u00e9ron","year":"2014","journal-title":"Rev Med Interne"},{"issue":"1","key":"10.1016\/j.rdc.2026.07.003_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archopht.120.1.15","article-title":"Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy","volume":"120","author":"Sainz de la Maza","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.rdc.2026.07.003_bib7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.rdc.2026.07.003_bib8","series-title":"StatPearls","article-title":"Peripheral ulcerative keratitis","author":"Fu","year":"2025"},{"key":"10.1016\/j.rdc.2026.07.003_bib9","series-title":"Keratitis - current perspectives","article-title":"Peripheral ulcerative keratitis associated with autoimmune diseases","author":"\u015awierczy\u0144ska","year":"2023"},{"key":"10.1016\/j.rdc.2026.07.003_bib10","series-title":"StatPearls","article-title":"Nonspecific orbital inflammation","author":"Zeppieri","year":"2025"},{"issue":"3","key":"10.1016\/j.rdc.2026.07.003_bib11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.rdc.2026.07.003_bib12","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.3390\/jcm11092525","article-title":"A comprehensive update on retinal vasculitis: etiologies, manifestations and treatments","volume":"11","author":"Agarwal","year":"2022","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.rdc.2026.07.003_bib13","first-page":"991","article-title":"Evaluation of the painful eye","volume":"93","author":"Pflipsen","year":"2016","journal-title":"Am Fam Physician"},{"issue":"3","key":"10.1016\/j.rdc.2026.07.003_bib14","first-page":"1","article-title":"What you need to know about assessing a patient with diplopia","volume":"29","author":"Chishty","year":"2023","journal-title":"Br J Hosp Med Lond Engl (Lond)"},{"key":"10.1016\/j.rdc.2026.07.003_bib15","series-title":"Autoimmunity: from bench to bedside [Internet]","article-title":"Autoimmune uveitis","author":"Amador-Patarroyo","year":"2013"},{"key":"10.1016\/j.rdc.2026.07.003_bib16","series-title":"StatPearls","article-title":"Uveitic macular edema","author":"Sood","year":"2025"},{"issue":"9451","key":"10.1016\/j.rdc.2026.07.003_bib17","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(04)17554-5","article-title":"The eye in systemic inflammatory diseases","volume":"364","author":"McCluskey","year":"2004","journal-title":"Lancet Lond Engl"},{"issue":"2","key":"10.1016\/j.rdc.2026.07.003_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s40123-021-00337-2","article-title":"Alleviating an increasingly burdened healthcare system with telemedicine: anterior segment","volume":"10","author":"Alawa","year":"2021","journal-title":"Ophthalmol Ther"},{"issue":"7","key":"10.1016\/j.rdc.2026.07.003_bib19","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ophtha.2015.02.032","article-title":"Automated analysis of anterior chamber inflammation by spectral-domain optical coherence tomography","volume":"122","author":"Sharma","year":"2015","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.rdc.2026.07.003_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/bjophthalmol-2015-308008","article-title":"Quantitative analysis of vitreous inflammation using optical coherence tomography in patients receiving sub-tenon\u2019s triamcinolone acetonide for uveitic cystoid macular oedema","volume":"101","author":"Sreekantam","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"18","key":"10.1016\/j.rdc.2026.07.003_bib21","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.3390\/jcm10184133","article-title":"Update on the management of uveitic macular edema","volume":"10","author":"Teper","year":"2021","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.rdc.2026.07.003_bib22","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/s41433-022-02120-4","article-title":"A fluorescein angiography-based computer-aided algorithm for assessing the retinal vasculature in diabetic retinopathy","volume":"37","author":"Abbasnejad","year":"2023","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.rdc.2026.07.003_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1869-5760-3-30","article-title":"Ultra-wide-field retinal imaging in the management of non-infectious retinal vasculitis","volume":"3","author":"Leder","year":"2013","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"Pt 5","key":"10.1016\/j.rdc.2026.07.003_bib24","first-page":"761","article-title":"Indocyanine green angiography in inflammatory eye disease","volume":"12","author":"Howe","year":"1998","journal-title":"Eye Lond Engl"},{"issue":"1","key":"10.1016\/j.rdc.2026.07.003_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/tjosr.tjosr_24_24","article-title":"Visualizing the spectrum: B-scan ultrasonography across diverse ocular abnormalities: a pictorial review","volume":"62","author":"Malgotra","year":"2024","journal-title":"Tnoa J Ophthalmic Sci Res"},{"issue":"12","key":"10.1016\/j.rdc.2026.07.003_bib26","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00234-018-2103-4","article-title":"CT and MR imaging of orbital inflammation","volume":"60","author":"Ferreira","year":"2018","journal-title":"Neuroradiology"},{"issue":"2 Suppl 2","key":"10.1016\/j.rdc.2026.07.003_bib27","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1016\/j.jaci.2009.09.041","article-title":"Diagnostic testing and interpretation of tests for autoimmunity","volume":"125","author":"Castro","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rdc.2026.07.003_bib28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajo.2021.03.061","article-title":"Development of classification criteria for the uveitides","volume":"228","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.rdc.2026.07.003_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2026.07.003_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.18773\/austprescr.2024.035","article-title":"Utility of common investigations for suspected inflammatory arthritis in adults","volume":"47","author":"Cook","year":"2024","journal-title":"Aust Prescr"},{"issue":"2","key":"10.1016\/j.rdc.2026.07.003_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.sjopt.2009.08.001","article-title":"Perspective: lacrimal gland biopsy, is it important?","volume":"23","author":"Malki","year":"2009","journal-title":"Saudi J Ophthalmol"},{"issue":"10","key":"10.1016\/j.rdc.2026.07.003_bib32","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.eye.6702383","article-title":"Orbital inflammatory disease: a diagnostic and therapeutic challenge","volume":"20","author":"Gordon","year":"2006","journal-title":"Eye"},{"issue":"9","key":"10.1016\/j.rdc.2026.07.003_bib33","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00417-018-4014-9","article-title":"Clinical features of different orbital manifestations of granulomatosis with polyangiitis","volume":"256","author":"Ismailova","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"issue":"7","key":"10.1016\/j.rdc.2026.07.003_bib34","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/rheumatology\/keac663","article-title":"Ocular manifestations of ANCA-associated vasculitis","volume":"62","author":"Junek","year":"2022","journal-title":"Rheumatol Oxf Engl"},{"issue":"7","key":"10.1016\/j.rdc.2026.07.003_bib35","article-title":"A comprehensive review of ocular manifestations in systemic diseases","volume":"16","author":"Kumar","year":"2024","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.rdc.2026.07.003_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.survophthal.2005.04.009","article-title":"Current concepts in the etiology and treatment of beh\u00e7et disease","volume":"50","author":"Evereklioglu","year":"2005","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.rdc.2026.07.003_bib37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12016-014-8425-z","article-title":"Ocular involvement of beh\u00e7et\u2019s syndrome: a comprehensive review","volume":"49","author":"Ozyazgan","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"21","key":"10.1016\/j.rdc.2026.07.003_bib38","doi-asserted-by":"crossref","first-page":"5174","DOI":"10.3390\/jcm10215174","article-title":"Ocular manifestations of beh\u00e7et\u2019s disease: an update on diagnostic challenges and disease management","volume":"10","author":"Zaj\u0105c","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.rdc.2026.07.003_bib39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/sjopt.sjopt_228_24","article-title":"Beh\u00e7et syndrome with eye involvement","volume":"39","author":"Ucar","year":"2025","journal-title":"Saudi J Ophthalmol"},{"issue":"7","key":"10.1016\/j.rdc.2026.07.003_bib40","first-page":"529","article-title":"[Ocular manifestations of Beh\u00e7et\u2019s disease]","volume":"150","author":"Cassoux","year":"1999","journal-title":"Ann Med Interne"},{"issue":"11","key":"10.1016\/j.rdc.2026.07.003_bib41","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.3390\/jcm12113648","article-title":"Beh\u00e7et\u2019s disease uveitis","volume":"12","author":"Joubert","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.rdc.2026.07.003_bib42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/09273948.2016.1206204","article-title":"Long-term efficacy of interferon in severe uveitis associated with beh\u00e7et disease","volume":"25","author":"Diwo","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.rdc.2026.07.003_bib43","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"2018 update of the EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2026.07.003_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fopht.2022.848861","article-title":"Giant cell arteritis: updates and controversies","volume":"2","author":"Yu","year":"2022","journal-title":"Front Ophthalmol"},{"issue":"3","key":"10.1016\/j.rdc.2026.07.003_bib45","doi-asserted-by":"crossref","first-page":"206","DOI":"10.7861\/clinmed.2022-0415","article-title":"Frequency of visual involvement in a 10-year interdisciplinary cohort of patients with giant cell arteritis","volume":"23","author":"Smith","year":"2023","journal-title":"Clin Med Lond Engl"},{"issue":"Suppl 3","key":"10.1016\/j.rdc.2026.07.003_bib46","doi-asserted-by":"crossref","first-page":"iii5","DOI":"10.1093\/rheumatology\/kez553","article-title":"Diagnosis of giant cell arteritis","volume":"59","author":"Ponte","year":"2020","journal-title":"Rheumatol Oxf Engl"},{"issue":"2","key":"10.1016\/j.rdc.2026.07.003_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/ijo.IJO_1681_20","article-title":"Giant cell arteritis: its ophthalmic manifestations","volume":"69","author":"Hayreh","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.rdc.2026.07.003_bib48","series-title":"StatPearls","article-title":"Amaurosis fugax","author":"Kaur","year":"2025"},{"key":"10.1016\/j.rdc.2026.07.003_bib49","article-title":"Characteristics of eye-related emergency visits and triage differences by nurses and ophthalmologists: perspective from a single eye center in southern China","volume":"10","author":"Chen","year":"2023","journal-title":"Front Med"},{"issue":"7","key":"10.1016\/j.rdc.2026.07.003_bib50","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.3390\/jcm11071997","article-title":"Ocular complications of giant cell arteritis: an acute therapeutic emergency","volume":"11","author":"H\u00e9ron","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.rdc.2026.07.003_bib52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/sjopt.sjopt_236_24","article-title":"Interdisciplinary approach in the management of visual loss in giant cell arteritis","volume":"39","author":"De Simone","year":"2024","journal-title":"Saudi J Ophthalmol"},{"issue":"3","key":"10.1016\/j.rdc.2026.07.003_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2024-262251","article-title":"Ocular ischaemic syndrome due to giant cell arteritis","volume":"18","author":"Wilkinson","year":"2025","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.rdc.2026.07.003_bib54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3899\/jrheum.190768","article-title":"Ocular manifestations in rheumatoid arthritis, connective tissue disease, and vasculitis: a systematic review and metaanalysis","volume":"48","author":"Turk","year":"2021","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2026.07.003_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102735","article-title":"Beyond the joints, the extra-articular manifestations in rheumatoid arthritis","volume":"20","author":"Conforti","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.rdc.2026.07.003_bib56","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1016\/j.ophtha.2023.12.041","article-title":"Dry eye syndrome preferred practice pattern\u00ae","volume":"131","author":"Amescua","year":"2024","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.rdc.2026.07.003_bib57","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.3390\/jcm10102118","article-title":"Rheumatoid arthritis associated episcleritis and scleritis: an update on treatment perspectives","volume":"10","author":"Promelle","year":"2021","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.rdc.2026.07.003_bib58","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.4103\/ijo.IJO_2032_20","article-title":"Scleritis: differentiating infectious from non-infectious entities","volume":"68","author":"Murthy","year":"2020","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"10.1016\/j.rdc.2026.07.003_bib59","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3899\/jrheum.170437","article-title":"Clinical correlates, outcomes, and predictors of inflammatory ocular disease associated with rheumatoid arthritis in the biologic era","volume":"45","author":"Caimmi","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2026.07.003_bib60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajo.2026.01.004","article-title":"Exploring the association between autoimmune and inflammatory diseases and uveitis","volume":"284","author":"Mohan","year":"2026","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.rdc.2026.07.003_bib61","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/ICU.0000000000000098","article-title":"Ocular manifestations of seronegative spondyloarthropathies","volume":"25","author":"Zagora","year":"2014","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"10.1016\/j.rdc.2026.07.003_bib62","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/ICU.0000000000000525","article-title":"Ocular features of the HLA-B27-positive seronegative spondyloarthropathies","volume":"29","author":"Jhaj","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.rdc.2026.07.003_bib63","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0161-6420(91)32268-1","article-title":"Ocular inflammation in Crohn\u2019s disease","volume":"98","author":"Salmon","year":"1991","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.rdc.2026.07.003_bib64","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ard.59.1.67","article-title":"Characterisation of uveitis in patients with psoriatic arthritis","volume":"59","author":"Paiva","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2026.07.003_bib65","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s10067-023-06834-y","article-title":"The risk factors for uveitis among psoriatic arthritis patients: a population-based cohort study","volume":"43","author":"Hijazi","year":"2024","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2026.07.003_bib66","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0161-6420(03)00620-1","article-title":"Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter\u2019s syndrome","volume":"110","author":"Kiss","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rdc.2026.07.003_bib67","series-title":"Kelley and Firestein\u2019s textbook of rheumatology","year":"2017"},{"key":"10.1016\/j.rdc.2026.07.003_bib68","series-title":"Orbital inflammatory diseases and their differential diagnosis","year":"2015"},{"issue":"4","key":"10.1016\/j.rdc.2026.07.003_bib69","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccm.2015.08.009","article-title":"Ocular sarcoidosis","volume":"36","author":"Pasadhika","year":"2015","journal-title":"Clin Chest Med"},{"issue":"5","key":"10.1016\/j.rdc.2026.07.003_bib70","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ajo.2007.07.019","article-title":"Diverse clinical presentations of orbital sarcoid","volume":"144","author":"Mavrikakis","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"14","key":"10.1016\/j.rdc.2026.07.003_bib71","first-page":"5479","article-title":"Computed tomographic and chest radiographic findings in patients with ocular sarcoidosis","volume":"53","author":"Lowder","year":"2012","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.rdc.2026.07.003_bib72","article-title":"IgG4-related disease presenting with profound bilateral orbital and adnexal inflammation","volume":"29","author":"Kutzscher","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"6","key":"10.1016\/j.rdc.2026.07.003_bib73","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.semarthrit.2013.11.008","article-title":"Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review","volume":"43","author":"Wallace","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2026.07.003_bib74","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006205","article-title":"Ophthalmic manifestations in IgG4-related disease: clinical presentation and response to treatment in a French case-series","volume":"96","author":"Ebbo","year":"2017","journal-title":"Medicine (Baltim)"},{"issue":"10","key":"10.1016\/j.rdc.2026.07.003_bib75","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006205","article-title":"Ophthalmic manifestations in IgG4-related disease","volume":"96","author":"Ebbo","year":"2017","journal-title":"Medicine (Baltim)"},{"issue":"5","key":"10.1016\/j.rdc.2026.07.003_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2024.100101","article-title":"Advances in understanding and management of IgG4-related ophthalmic disease","volume":"13","author":"Lai","year":"2024","journal-title":"Asia-Pac J Ophthalmol"},{"issue":"4","key":"10.1016\/j.rdc.2026.07.003_bib77","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00330-016-4481-5","article-title":"Infraorbital nerve involvement on magnetic resonance imaging in European patients with IgG4-related ophthalmic disease: a specific sign","volume":"27","author":"Soussan","year":"2017","journal-title":"Eur Radiol"},{"issue":"13","key":"10.1016\/j.rdc.2026.07.003_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13133780","article-title":"Unraveling the clinical features and outcomes of IgG4-Related ophthalmic disease","volume":"13","author":"Kim","year":"2024","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.rdc.2026.07.003_bib79","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41584-020-0500-7","article-title":"IgG4-related disease: an update on pathophysiology and implications for clinical care","volume":"16","author":"Perugino","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2026.07.003_bib80","doi-asserted-by":"crossref","first-page":"574","DOI":"10.11622\/smedj.2021226","article-title":"Imaging findings of immunoglobulin G4-related disease: from the head to the pelvis","volume":"62","author":"Ichikawa","year":"2021","journal-title":"Singap Med J"},{"issue":"1","key":"10.1016\/j.rdc.2026.07.003_bib81","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019 American college of Rheumatology\/European League against rheumatism classification criteria for IgG4-Related disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"1","key":"10.1016\/j.rdc.2026.07.003_bib82","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/bjophthalmol-2015-306629","article-title":"Ocular manifestations in systemic lupus erythematosus","volume":"100","author":"Silpa-archa","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.rdc.2026.07.003_bib83","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.2147\/JIR.S288294","article-title":"Topical anti-inflammatory agents for non-infectious uveitis: current treatment and perspectives","volume":"15","author":"Balasubramaniam","year":"2022","journal-title":"J Inflamm Res"},{"issue":"5","key":"10.1016\/j.rdc.2026.07.003_bib84","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/IAE.0000000000001243","article-title":"Resolution of noninfectious uveitic cystoid macular edema with topical difluprednate","volume":"37","author":"Feiler","year":"2017","journal-title":"Retina"},{"issue":"9","key":"10.1016\/j.rdc.2026.07.003_bib85","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/bjo.2003.037226","article-title":"Degree, duration, and causes of visual loss in uveitis","volume":"88","author":"Durrani","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.rdc.2026.07.003_bib86","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ophtha.2018.08.021","article-title":"Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone implant for the treatment of uveitic macular edema","volume":"126","author":"Thorne","year":"2019","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.rdc.2026.07.003_bib87","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ophtha.2020.04.001","article-title":"Effect of a fluocinolone acetonide insert on recurrence rates in noninfectious intermediate, posterior, or panuveitis","volume":"127","author":"Jaffe","year":"2020","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.rdc.2026.07.003_bib88","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/ceo.13702","article-title":"Local delivery of corticosteroids in clinical ophthalmology: a review","volume":"48","author":"Fung","year":"2020","journal-title":"Clin Experiment Ophthalmol"},{"issue":"19","key":"10.1016\/j.rdc.2026.07.003_bib89","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2017.5103","article-title":"Association between long-lasting intravitreous fluocinolone acetonide implant vs systemic anti-inflammatory therapy and visual acuity at 7 years among patients with intermediate, posterior, or panuveitis","volume":"317","author":"Kempen","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.rdc.2026.07.003_bib90","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ajo.2009.09.026","article-title":"Mycophenolate mofetil for ocular inflammation","volume":"149","author":"Daniel","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.rdc.2026.07.003_bib91","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.ophtha.2008.04.026","article-title":"Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation","volume":"115","author":"Galor","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rdc.2026.07.003_bib92","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajo.2019.07.008","article-title":"Comparison between methotrexate and mycophenolate mofetil monotherapy for the control of noninfectious ocular inflammatory diseases","volume":"208","author":"Gangaputra","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.rdc.2026.07.003_bib93","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.ophtha.2014.04.023","article-title":"A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis","volume":"121","author":"Rathinam","year":"2014","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.rdc.2026.07.003_bib94","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ophtha.2009.06.060","article-title":"Cyclophosphamide for ocular inflammatory diseases","volume":"117","author":"Pujari","year":"2010","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.rdc.2026.07.003_bib95","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2009.08.010","article-title":"Cyclosporine for ocular inflammatory diseases","volume":"117","author":"Ka\u00e7maz","year":"2010","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.rdc.2026.07.003_bib96","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/1744666X.2020.1798230","article-title":"The current status of biological treatment for uveitis","volume":"16","author":"Gaggiano","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2026.07.003_bib97","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ophtha.2013.07.019","article-title":"Infliximab for the treatment of refractory noninfectious uveitis: a study of 88 patients with long-term Follow-up","volume":"121","author":"Kruh","year":"2014","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.rdc.2026.07.003_bib98","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2019-000331","article-title":"Ocular side effects of antirheumatic medications: a qualitative review","volume":"5","author":"M Castillejo Becerra","year":"2020","journal-title":"BMJ Open Ophthalmol"},{"issue":"4","key":"10.1016\/j.rdc.2026.07.003_bib99","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.rdc.2026.07.003_bib100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41433-025-04065-w","article-title":"The use of Janus kinase inhibitors to treat noninfectious uveitis","volume":"40","author":"Beckman","year":"2026","journal-title":"Eye"},{"key":"10.1016\/j.rdc.2026.07.003_bib101","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/2324400","article-title":"Role of Janus Kinase (JAK) inhibitor in autoimmune ocular inflammation: a systematic review","volume":"2021","author":"Wen","year":"2021","journal-title":"J Immunol Res"},{"issue":"20","key":"10.1016\/j.rdc.2026.07.003_bib102","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMoa2413449","article-title":"A phase 3 trial of upadacitinib for giant-cell arteritis","volume":"392","author":"Blockmans","year":"2025","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.rdc.2026.07.003_bib103","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1136\/ard-2024-225933","article-title":"Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b\/3 trials","volume":"83","author":"Brown","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.rdc.2026.07.003_bib104","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1056\/NEJMoa2409712","article-title":"Inebilizumab for treatment of IgG4-Related disease","volume":"392","author":"Stone","year":"2025","journal-title":"N Engl J Med"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X26000554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X26000554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:27:09Z","timestamp":1791509229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X26000554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":103,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0889857X26000554"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2026.07.003","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular Manifestations in Rheumatic Diseases","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2026.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}